Recently emerged severe acute respiratory syndrome coronavirus (SARS-CoV)-1 and-2
initiate virus infection by binding of their spike glycoprotein with the cell-surface receptor …

Soluble angiotensin-converting enzyme 2 (sACE2) could be a therapeutic option to treat
coronavirus disease 2019 (COVID-19) infection. Severe acute respiratory syndrome …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the
recent pandemic COVID-19, is reported to have originated from bats, with its intermediate …

Abstract Angiotensin-converting enzyme 2 (ACE2) has been identified as the host entry
receptor for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible …

A novel coronavirus disease, COVID-19, has created a global pandemic in 2020, posing an
enormous challenge to healthcare systems and affected communities. COVID-19 is caused …

Angiotensin-converting enzyme (ACE) and its homologue, ACE2, are commonly allied with
hypertension, renin–angiotensin–aldosterone system pathway, and other cardiovascular …

The COVID-19 pandemic has caused an unprecedented global public health and economic
crisis. The origin and emergence of its causal agent, SARS-CoV-2, in the human population …

Dear Editor, Since December 2019, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) has caused a pneumonia outbreak in Wuhan city, China, followed by global …

A new virus belonging to the coronaviridae family has been identified and named severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2)(Zhu et al., 2020). This virus can …

It has been reported that SARS-CoV-2 may use ACE2 as a receptor to gain entry into human
cells, in a way similar to that of SARS-CoV. Analyzing the distribution and expression level of …